For example, by using antibodies or peptides that can bind to cancer-associated transmembrane receptors, surface-modified nanoparticles can specifically target cancer cells, increasing the efficacy of cancer treatments while reducing side effects [6,7,41]. This evidence concerns the gene NRP1 and cancer.